Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas.
about
Morpholino-Mediated Isoform Modulation of Vascular Endothelial Growth Factor Receptor-2 (VEGFR2) Reduces Colon Cancer Xenograft Growth.Immune-checkpoint blockade and active immunotherapy for glioma.Sunitinib impedes brain tumor progression and reduces tumor-induced neurodegeneration in the microenvironment.Targeting the extradomain A of fibronectin allows identification of vascular resistance to antiangiogenic therapy in experimental glioma.
P2860
Combined temozolomide and sunitinib treatment leads to better tumour control but increased vascular resistance in O6-methylguanine methyltransferase-methylated gliomas.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Combined temozolomide and suni ...... ransferase-methylated gliomas.
@en
Combined temozolomide and suni ...... ransferase-methylated gliomas.
@nl
type
label
Combined temozolomide and suni ...... ransferase-methylated gliomas.
@en
Combined temozolomide and suni ...... ransferase-methylated gliomas.
@nl
prefLabel
Combined temozolomide and suni ...... ransferase-methylated gliomas.
@en
Combined temozolomide and suni ...... ransferase-methylated gliomas.
@nl
P2093
P1476
Combined temozolomide and suni ...... ransferase-methylated gliomas.
@en
P2093
A Jabouille
F L Heppner
G Parmaksiz
I Kremenetskaia
J Bruenner
M Czabanka
M Nieminen
M Topalovic
P304
P356
10.1016/J.EJCA.2013.02.019
P577
2013-03-14T00:00:00Z